Unlocking precision: nitrosamine and NDSRI analysis

We invite you to join our webinar on nitrosamine and NDSRIs, specifically examining their analysis and implications in the pharmaceutical industry. Nitrosamines, a group of potentially carcinogenic impurities, have gained considerable attention in recent years because of their presence in certain drug substances. It is essential to understand their analytical characteristics to ensure patient safety and adhere to regulatory guidelines. Let’s delve into the world of pharmaceutical analysis together!

Discussion points:

• Understanding nitrosamines and NDSRIs: an overview
• Analytical techniques for detection and quantification
• Regulatory landscape and compliance
• Real case studies of drug substances
• Column selection for nitrosamines analysis